VF
TNXP icon

Virtu Financial’s Tonix Pharmaceuticals TNXP Stock Holding History

Virtu Financial’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,878
Closed -$302K – 2030
2025
Q1 		$302K Buy
16,878
+16,239
+2,541% +$329K 0.02% 669
2024
Q4 		$21K Sell
639
-723
-53% -$15K ﹤0.01% 1292
2024
Q3 		$20K Buy
+1,362
New +$54.8K ﹤0.01% 1128
2024
Q2 		– Sell
-7
Closed -$4K – 1881
2024
Q1 		$4K Buy
+7
New +$7.54K ﹤0.01% 1303
2023
Q4 		– Sell
-21
Closed -$37K – 2004
2023
Q3 		$37K Buy
+21
New +$76.8K ﹤0.01% 936
2023
Q2 		– Sell
-3
Closed -$35K – 2042
2023
Q1 		$35K Sell
3
-6
-67% -$103K ﹤0.01% 1157
2022
Q4 		$73K Buy
9
+3
+50% +$25.9K 0.01% 1018
2022
Q3 		$69K Buy
+6
New +$147K 0.01% 1144
2022
Q1 		– Hold
0
– -$110K – 2035
2021
Q4 		– Sell
-1
Closed -$318K – 1091
2021
Q3 		$441K Buy
+1
New +$487K 0.04% 524
2021
Q2 		– Hold
0
– – – 677
2020
Q4 		– Hold
0
– -$79K – 1799
2020
Q3 		– Hold
0
– – – 754
2018
Q4 		– Hold
0
– -$13K – 1988
2018
Q3 		– Hold
0
– – – 1435
2018
Q2 		– Hold
0
– -$57K – 2500
2018
Q1 		– Hold
0
– – – 1689
2017
Q4 		– Hold
0
– – – 1982
2017
Q3 		– Hold
0
– – – 2208

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's TNXP Position: Q2 2025 in Review

Virtu Financial sold out of Tonix Pharmaceuticals (TNXP) in Q2 2025, closing a stake of 16,878 shares — an estimated $302K sold.

Virtu Financial first reported a position in TNXP in Q3 2021 and held it in 9 quarters. The position peaked at $441K in Q3 2021. 47 funds tracked by Wall St. Rank hold TNXP as of Q2 2025.

  • Virtu Financial reported no remaining Tonix Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Virtu Financial sold 16,878 Tonix Pharmaceuticals shares in Q2 2025, an estimated $302K.
  • Virtu Financial first reported a position in Tonix Pharmaceuticals in Q3 2021 and held it in 9 quarters.
  • Virtu Financial's Tonix Pharmaceuticals position peaked at $441K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.